## Note
nid: 1472502605856
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#B&B::05_Cardio::02_Ischemia::05_Stable_Angina, #AK_Step1_v11::#FirstAid::07_Cardiovascular::05_Pharm::03_Calcium_Channel_Blockers, #AK_Step1_v11::#FirstAid::07_Cardiovascular::05_Pharm::07_Antianginal_Therapy, #AK_Step1_v11::#OME_banner::Basic_Science::09_Cardiac, #AK_Step1_v11::#Physeo::09_Pharm::10_Cardiac::01_Hypertension_Treatment, #AK_Step1_v11::#Physeo::09_Pharm::10_Cardiac::02_Calcium_Channel_Blockers, #AK_Step1_v11::#SketchyPharm::02_Cardio_&_Renal::03_Antihypertensives::01_Calcium_channel_blockers, #AK_Step1_v11::^Other::^HighYield::2-RelativelyHighYield, #AK_Step1_v11::^Systems::Cardio::Pharmacology, #AK_Step2_v11::#B&B::01_Cardiology::Pharm::CVS_Pharm_1
markdown: false

### Text
<div>
  <b>Non-dihydropyridine CCBs</b> are useful for treating angina
  due to their ability to <u>decrease</u> {{c1::myocardial oxygen}}
  demand
</div>

### Extra
<div>
  <i>decreased demand due to negative inotropic and chronotropic
  effects</i>
</div>
<div><img src="paste-436282777928154.jpg"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="paste-666785082769411.jpg"><img src=
"paste-60816736911363%20(1).jpg">

### Sketchy
<div>
  <i>Sketchy Pharmacology: Calcium Channel Blockers (CCBs)</i>
</div><img src=
"Screen%20Shot%202019-09-18%20at%209.10.20%20AM.png"> <img src=
"Screen%20Shot%202019-09-18%20at%209.10.30%20AM.png"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-cardiovascular-renal/videos/medical-pharmacology-cardiovascular-and-renal-antihypertensives-calcium-channel-blockers?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch Calcium channel blockers</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org/spa/cardiac?ref=anki"><img src=
  "_OME_AnkiFlashcards_Topic_5.png"></a>
</div>

### Additional Resources


### One by one

